Sudden Arrhythmic Death at the Higher End of the Heart Failure Spectrum

Apostolos Dimos1, Andrew Xanthopoulos1, Michail Papamichalis1

  • 1Department of Cardiology, University General Hospital of Larissa, Larisa, Greece.

Angiology
|December 27, 2019
PubMed

Insights

Sudden cardiac death (SCD) risk is high in heart failure (HF). This review focuses on preventing sudden arrhythmic death (SAD) in HF patients with preserved ejection fraction, addressing knowledge gaps.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Sudden cardiac death (SCD) poses a significant risk to heart failure (HF) patients.
  • Sudden arrhythmic death (SAD) is a primary cause of mortality in HF patients with reduced ejection fraction, managed with implantable cardioverter-defibrillators.
  • Etiology and prevention of SCD in HF patients with near-normal/normal left ventricular ejection fraction (LVEF) remain less understood.

Purpose of the Study:

  • To review the epidemiology of SCD in HF patients with preserved LVEF.
  • To summarize the underlying mechanisms of SAD in this population.
  • To propose a diagnostic and prevention strategy for SAD in HF with near-normal/normal LVEF.

Main Methods:

  • Literature review of epidemiological data on SCD in HF.
  • Synthesis of proposed mechanisms for SAD in HF with preserved LVEF.
  • Development of a stepwise clinical approach for SAD prevention.

Main Results:

  • The majority of out-of-hospital SCD cases occur in patients with unknown or normal/near-normal LVEF.
  • Specific mechanisms contributing to SAD in this cohort require further elucidation.
  • A structured diagnostic and therapeutic pathway is proposed for risk stratification and intervention.

Conclusions:

  • HF patients with near-normal/normal LVEF are also at risk for SCD.
  • Understanding the specific causes and implementing targeted prevention strategies are crucial.
  • Further research is needed to refine diagnostic tools and therapeutic options for this patient group.

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
388
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
404
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
311
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
263
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
207